The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Congleton Jon since 2015.
This trader's CIK number is 1644975.
At the time of last reporting, Congleton Jon was the Chief Executive Officer of Mineralys Therapeutics, Inc.. (stock ticker symbol MLYS).
Also see all insider trading activities at Mineralys Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MLYS | 0 | $0 | 49,536 | $583,306 | 0 | $0 |
| 2024 | MLYS | 0 | $0 | 153,127 | $1,932,733 | 0 | $0 |
| 2023 | MLYS | 10,750 | $105,540 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | NVLS | 10,000 | $40,430 | 0 | $0 | 0 | $0 |
| 2015 | NVLS | 5,000 | $40,500 | 0 | $0 | 0 | $0 |
1. Mineralys Therapeutics, Inc. (MLYS)
2. Alpine Immune Sciences, Inc. (NVLS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-11 | MLYS | Sale | 15,884 | 14.51 | 230,429 |
| 2025-04-11 | MLYS | Sale | 15,319 | 12.19 | 186,799 |
| 2025-01-13 | MLYS | Sale | 18,333 | 9.06 | 166,078 |
| 2024-10-11 | MLYS | Sale | 15,271 | 13.52 | 206,433 |
| 2024-07-11 | MLYS | Sale | 15,746 | 13.34 | 210,083 |
| 2024-06-17 | MLYS | Sale | 17,766 | 12.25 | 217,704 |
| 2024-06-18 | MLYS | Sale | 16,607 | 11.99 | 199,068 |
| 2024-06-20 | MLYS | Sale | 14,940 | 11.73 | 175,231 |
| 2024-06-12 | MLYS | Sale | 16,607 | 12.77 | 212,021 |
| 2024-06-13 | MLYS | Sale | 39,961 | 12.74 | 509,023 |
| 2024-06-14 | MLYS | Sale | 16,229 | 12.52 | 203,170 |
| 2023-11-22 | MLYS | Buy | 4,250 | 5.97 | 25,355 |
| 2023-09-06 | MLYS | Buy | 2,250 | 12.08 | 27,180 |
| 2023-08-17 | MLYS | Buy | 2,250 | 12.10 | 27,225 |
| 2023-08-11 | MLYS | Buy | 2,000 | 12.89 | 25,780 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-06-16 | NVLS | Buy | 5,000 | 3.87 | 19,345 |
| 2016-03-24 | NVLS | Buy | 5,000 | 4.22 | 21,085 |
| 2015-12-11 | NVLS | Buy | 5,000 | 8.10 | 40,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Congleton Jon (Chief Executive Officer of Mineralys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.